 | • レポートコード：QFJ1-4738 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、心的外傷後ストレス障害治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗うつ薬、抗不安薬、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・心的外傷後ストレス障害治療薬の市場動向 ・企業の競争状況、市場シェア ・心的外傷後ストレス障害治療薬の種類別市場規模と予測2016-2027（抗うつ薬、抗不安薬、その他） ・心的外傷後ストレス障害治療薬の用途別市場規模と予測2016-2027（病院、クリニック、その他） ・心的外傷後ストレス障害治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・心的外傷後ストレス障害治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・心的外傷後ストレス障害治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・心的外傷後ストレス障害治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・心的外傷後ストレス障害治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer, Inc.、GlaxoSmithKline plc、Otsuka Pharmaceutical Co., Ltd、Novartis AG、AstraZeneca Plc、Azevan Pharmaceuticals, Inc.、Bionomics Ltd.、Tonix Pharmaceuticals Holding Corp.、Apotex, Inc.） ・結論 |
The main treatments for post-traumatic stress disorder (PTSD) are psychological therapies and medication.
Market Analysis and Insights: Global Post-Traumatic Stress Disorder Therapeutics Market
The global Post-Traumatic Stress Disorder Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Post-Traumatic Stress Disorder Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Post-Traumatic Stress Disorder Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Post-Traumatic Stress Disorder Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Post-Traumatic Stress Disorder Therapeutics market.
Global Post-Traumatic Stress Disorder Therapeutics Scope and Market Size
Post-Traumatic Stress Disorder Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Post-Traumatic Stress Disorder Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Antidepressants
Anti-Anxiety Drugs
Others
Segment by Application
Hospitals
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer, Inc.
GlaxoSmithKline plc
Otsuka Pharmaceutical Co., Ltd
Novartis AG
AstraZeneca Plc
Azevan Pharmaceuticals, Inc.
Bionomics Ltd.
Tonix Pharmaceuticals Holding Corp.
Apotex, Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Post-Traumatic Stress Disorder Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antidepressants
1.2.3 Anti-Anxiety Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Post-Traumatic Stress Disorder Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Post-Traumatic Stress Disorder Therapeutics Market Perspective (2016-2027)
2.2 Post-Traumatic Stress Disorder Therapeutics Growth Trends by Regions
2.2.1 Post-Traumatic Stress Disorder Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Post-Traumatic Stress Disorder Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Post-Traumatic Stress Disorder Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Post-Traumatic Stress Disorder Therapeutics Industry Dynamic
2.3.1 Post-Traumatic Stress Disorder Therapeutics Market Trends
2.3.2 Post-Traumatic Stress Disorder Therapeutics Market Drivers
2.3.3 Post-Traumatic Stress Disorder Therapeutics Market Challenges
2.3.4 Post-Traumatic Stress Disorder Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Post-Traumatic Stress Disorder Therapeutics Players by Revenue
3.1.1 Global Top Post-Traumatic Stress Disorder Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Post-Traumatic Stress Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Post-Traumatic Stress Disorder Therapeutics Revenue
3.4 Global Post-Traumatic Stress Disorder Therapeutics Market Concentration Ratio
3.4.1 Global Post-Traumatic Stress Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Post-Traumatic Stress Disorder Therapeutics Revenue in 2020
3.5 Post-Traumatic Stress Disorder Therapeutics Key Players Head office and Area Served
3.6 Key Players Post-Traumatic Stress Disorder Therapeutics Product Solution and Service
3.7 Date of Enter into Post-Traumatic Stress Disorder Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Post-Traumatic Stress Disorder Therapeutics Breakdown Data by Type
4.1 Global Post-Traumatic Stress Disorder Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Post-Traumatic Stress Disorder Therapeutics Forecasted Market Size by Type (2022-2027)
5 Post-Traumatic Stress Disorder Therapeutics Breakdown Data by Application
5.1 Global Post-Traumatic Stress Disorder Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Post-Traumatic Stress Disorder Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Post-Traumatic Stress Disorder Therapeutics Market Size (2016-2027)
6.2 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Type
6.2.1 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2016-2027)
6.3 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Application
6.3.1 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2016-2027)
6.4 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Country
6.4.1 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Post-Traumatic Stress Disorder Therapeutics Market Size (2016-2027)
7.2 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Type
7.2.1 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2016-2027)
7.3 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Application
7.3.1 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2016-2027)
7.4 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Country
7.4.1 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Type
8.2.1 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Application
8.3.1 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Region
8.4.1 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Post-Traumatic Stress Disorder Therapeutics Market Size (2016-2027)
9.2 Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Type
9.2.1 Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Application
9.3.1 Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Country
9.4.1 Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Type
10.2.1 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Application
10.3.1 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Country
10.4.1 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer, Inc.
11.1.1 Pfizer, Inc. Company Details
11.1.2 Pfizer, Inc. Business Overview
11.1.3 Pfizer, Inc. Post-Traumatic Stress Disorder Therapeutics Introduction
11.1.4 Pfizer, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021)
11.1.5 Pfizer, Inc. Recent Development
11.2 GlaxoSmithKline plc
11.2.1 GlaxoSmithKline plc Company Details
11.2.2 GlaxoSmithKline plc Business Overview
11.2.3 GlaxoSmithKline plc Post-Traumatic Stress Disorder Therapeutics Introduction
11.2.4 GlaxoSmithKline plc Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021)
11.2.5 GlaxoSmithKline plc Recent Development
11.3 Otsuka Pharmaceutical Co., Ltd
11.3.1 Otsuka Pharmaceutical Co., Ltd Company Details
11.3.2 Otsuka Pharmaceutical Co., Ltd Business Overview
11.3.3 Otsuka Pharmaceutical Co., Ltd Post-Traumatic Stress Disorder Therapeutics Introduction
11.3.4 Otsuka Pharmaceutical Co., Ltd Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021)
11.3.5 Otsuka Pharmaceutical Co., Ltd Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Post-Traumatic Stress Disorder Therapeutics Introduction
11.4.4 Novartis AG Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021)
11.4.5 Novartis AG Recent Development
11.5 AstraZeneca Plc
11.5.1 AstraZeneca Plc Company Details
11.5.2 AstraZeneca Plc Business Overview
11.5.3 AstraZeneca Plc Post-Traumatic Stress Disorder Therapeutics Introduction
11.5.4 AstraZeneca Plc Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021)
11.5.5 AstraZeneca Plc Recent Development
11.6 Azevan Pharmaceuticals, Inc.
11.6.1 Azevan Pharmaceuticals, Inc. Company Details
11.6.2 Azevan Pharmaceuticals, Inc. Business Overview
11.6.3 Azevan Pharmaceuticals, Inc. Post-Traumatic Stress Disorder Therapeutics Introduction
11.6.4 Azevan Pharmaceuticals, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021)
11.6.5 Azevan Pharmaceuticals, Inc. Recent Development
11.7 Bionomics Ltd.
11.7.1 Bionomics Ltd. Company Details
11.7.2 Bionomics Ltd. Business Overview
11.7.3 Bionomics Ltd. Post-Traumatic Stress Disorder Therapeutics Introduction
11.7.4 Bionomics Ltd. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021)
11.7.5 Bionomics Ltd. Recent Development
11.8 Tonix Pharmaceuticals Holding Corp.
11.8.1 Tonix Pharmaceuticals Holding Corp. Company Details
11.8.2 Tonix Pharmaceuticals Holding Corp. Business Overview
11.8.3 Tonix Pharmaceuticals Holding Corp. Post-Traumatic Stress Disorder Therapeutics Introduction
11.8.4 Tonix Pharmaceuticals Holding Corp. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021)
11.8.5 Tonix Pharmaceuticals Holding Corp. Recent Development
11.9 Apotex, Inc.
11.9.1 Apotex, Inc. Company Details
11.9.2 Apotex, Inc. Business Overview
11.9.3 Apotex, Inc. Post-Traumatic Stress Disorder Therapeutics Introduction
11.9.4 Apotex, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021)
11.9.5 Apotex, Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Post-Traumatic Stress Disorder Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antidepressants
Table 3. Key Players of Anti-Anxiety Drugs
Table 4. Key Players of Others
Table 5. Global Post-Traumatic Stress Disorder Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Post-Traumatic Stress Disorder Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Post-Traumatic Stress Disorder Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Post-Traumatic Stress Disorder Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Regions (2022-2027)
Table 11. Post-Traumatic Stress Disorder Therapeutics Market Trends
Table 12. Post-Traumatic Stress Disorder Therapeutics Market Drivers
Table 13. Post-Traumatic Stress Disorder Therapeutics Market Challenges
Table 14. Post-Traumatic Stress Disorder Therapeutics Market Restraints
Table 15. Global Post-Traumatic Stress Disorder Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Post-Traumatic Stress Disorder Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Post-Traumatic Stress Disorder Therapeutics as of 2020)
Table 18. Ranking of Global Top Post-Traumatic Stress Disorder Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Post-Traumatic Stress Disorder Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Post-Traumatic Stress Disorder Therapeutics Product Solution and Service
Table 22. Date of Enter into Post-Traumatic Stress Disorder Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Post-Traumatic Stress Disorder Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Post-Traumatic Stress Disorder Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Post-Traumatic Stress Disorder Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer, Inc. Company Details
Table 63. Pfizer, Inc. Business Overview
Table 64. Pfizer, Inc. Post-Traumatic Stress Disorder Therapeutics Product
Table 65. Pfizer, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Pfizer, Inc. Recent Development
Table 67. GlaxoSmithKline plc Company Details
Table 68. GlaxoSmithKline plc Business Overview
Table 69. GlaxoSmithKline plc Post-Traumatic Stress Disorder Therapeutics Product
Table 70. GlaxoSmithKline plc Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 71. GlaxoSmithKline plc Recent Development
Table 72. Otsuka Pharmaceutical Co., Ltd Company Details
Table 73. Otsuka Pharmaceutical Co., Ltd Business Overview
Table 74. Otsuka Pharmaceutical Co., Ltd Post-Traumatic Stress Disorder Therapeutics Product
Table 75. Otsuka Pharmaceutical Co., Ltd Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Otsuka Pharmaceutical Co., Ltd Recent Development
Table 77. Novartis AG Company Details
Table 78. Novartis AG Business Overview
Table 79. Novartis AG Post-Traumatic Stress Disorder Therapeutics Product
Table 80. Novartis AG Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Novartis AG Recent Development
Table 82. AstraZeneca Plc Company Details
Table 83. AstraZeneca Plc Business Overview
Table 84. AstraZeneca Plc Post-Traumatic Stress Disorder Therapeutics Product
Table 85. AstraZeneca Plc Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 86. AstraZeneca Plc Recent Development
Table 87. Azevan Pharmaceuticals, Inc. Company Details
Table 88. Azevan Pharmaceuticals, Inc. Business Overview
Table 89. Azevan Pharmaceuticals, Inc. Post-Traumatic Stress Disorder Therapeutics Product
Table 90. Azevan Pharmaceuticals, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Azevan Pharmaceuticals, Inc. Recent Development
Table 92. Bionomics Ltd. Company Details
Table 93. Bionomics Ltd. Business Overview
Table 94. Bionomics Ltd. Post-Traumatic Stress Disorder Therapeutics Product
Table 95. Bionomics Ltd. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Bionomics Ltd. Recent Development
Table 97. Tonix Pharmaceuticals Holding Corp. Company Details
Table 98. Tonix Pharmaceuticals Holding Corp. Business Overview
Table 99. Tonix Pharmaceuticals Holding Corp. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Tonix Pharmaceuticals Holding Corp. Recent Development
Table 101. Apotex, Inc. Company Details
Table 102. Apotex, Inc. Business Overview
Table 103. Apotex, Inc. Post-Traumatic Stress Disorder Therapeutics Product
Table 104. Apotex, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Apotex, Inc. Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Antidepressants Features
Figure 3. Anti-Anxiety Drugs Features
Figure 4. Others Features
Figure 5. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Post-Traumatic Stress Disorder Therapeutics Report Years Considered
Figure 10. Global Post-Traumatic Stress Disorder Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Post-Traumatic Stress Disorder Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Players in 2020
Figure 15. Global Top Post-Traumatic Stress Disorder Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Post-Traumatic Stress Disorder Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Post-Traumatic Stress Disorder Therapeutics Revenue in 2020
Figure 17. Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Post-Traumatic Stress Disorder Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Post-Traumatic Stress Disorder Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Post-Traumatic Stress Disorder Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Post-Traumatic Stress Disorder Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Post-Traumatic Stress Disorder Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Post-Traumatic Stress Disorder Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Share by Region (2016-2027)
Figure 39. China Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Post-Traumatic Stress Disorder Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Post-Traumatic Stress Disorder Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Post-Traumatic Stress Disorder Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021)
Figure 59. GlaxoSmithKline plc Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021)
Figure 60. Otsuka Pharmaceutical Co., Ltd Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021)
Figure 61. Novartis AG Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021)
Figure 62. AstraZeneca Plc Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021)
Figure 63. Azevan Pharmaceuticals, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021)
Figure 64. Bionomics Ltd. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021)
Figure 65. Tonix Pharmaceuticals Holding Corp. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021)
Figure 66. Apotex, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
心的外傷後ストレス障害治療法のグローバル市場：規模・現状・予測2019-2025 The main treatments for post-traumatic stress disorder (PTSD) are psychological therapies and medication.In 2018, the global Post-Traumatic Stress Disorder Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. …- 心的外傷後ストレス障害治療法のグローバル市場：規模・現状・予測2019-2025 The main treatments for post-traumatic stress disorder (PTSD) are psychological therapies and medication.In 2018, the global Post-Traumatic Stress Disorder Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. …
- 世界の心的外傷後ストレス障害治療市場規模・現状・予測（2021年-2027年） The main treatments for post-traumatic stress disorder (PTSD) are psychological therapies and medication. Market Analysis and Insights: Global Post-Traumatic Stress Disorder Treatment Market The global Post-Traumatic Stress Disorder Treatment market size is projected to reach US$ XX million by 2027,…
- 世界の慢性外傷性脳症（CTE）市場規模・現状・予測（2021年-2027年） Chronic traumatic encephalopathy (CTE) is a kind of degenerative brain disease that is found in athletes, military veterans, and others with a history of repetitive brain trauma. Market Analysis and Insights: Global Chronic Traumatic Encephalopathy (CTE) Market The global Chronic Traumatic Encephalo…
- 外傷性脳損傷治療薬のグローバル市場調査 2019年 The global Traumatic Brain Injury Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Traumatic Brain Injury Therapeutics volume and value at global level, regional level and company level.…